Nearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...
Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...
A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and ...
Just like its sister medication, Ozempic, Wegovy has been linked to lower risks of cardiovascular disease and other causes of ...
A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...
Nurse Practitioner Paige Hood said a lot of patients can make all the recommended lifestyle changes and still have trouble ...
The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...